quinaldic acid inhibits proliferation of colon cancer ht-29 cells in vitro: effects on signaling pathways

European Journal of Pharmacology
Ewa LangnerGrażyna Rajtar

Abstract

Quinaldic acid is presumed to be a derivative of kynurenic acid, a tryptophan metabolite with proven antiproliferative activity towards cancer cells in vitro. The aim of present study was to evaluate the activity of quinaldic acid in colon cancer cells. The antiproliferative potential of quinaldic acid was assessed in HT-29, LS180 and Caco-2 cells. Suppression of metabolic activity (IC50 of 0.5mM for HT-29 and LS180 cells, 0.9mM for Caco-2 cells) and DNA synthesis (IC50 of 2.7, 4.3, 2mM for HT-29, LS180 and Caco-2 cells, respectively) were observed in all tested cell lines. It is noteworthy that quinaldic acid in antiproliferative concentrations was non-toxic to normal colon epithelium CCD 841 CoTr cells. Concomitantly, alterations in several signaling pathways in HT-29 cells were observed. Quinaldic acid led to changes in the phosphorylation level of extracellular-signal-regulated kinase (ERK) 1/2, p38, cAMP response element-binding protein (CREB) and Akt (protein kinase B) kinases. Moreover, changes in the CREB transcription factor were also found at the gene expression level. Antiproliferative activity and signaling pathways modulatory potential of quinaldic acid in colon cancer cells in vitro has been stated.

References

Mar 1, 1978·Journal of Neurochemistry·E M Gál, A D Sherman
Jul 24, 1974·Biochemical and Biophysical Research Communications·H OkamotoR Takeda
Aug 21, 1973·Biochemical and Biophysical Research Communications·H OkamotoR Takeda
Jul 11, 1998·Journal of Neural Transmission·I YokoiN Ogawa
May 31, 2002·Acta Crystallographica. Section B, Structural Science·Frank H Allen
Jun 29, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alex A Adjei, Manuel Hidalgo
Jan 31, 2008·Amino Acids·Michal P TurskiWaldemar A Turski
Jul 23, 2008·Current Opinion in Pharmacology·Ensar Halilovic, David B Solit
Oct 7, 2008·Amino Acids·Piotr PaluszkiewiczWaldemar A Turski
Jul 28, 2010·Gastroenterology·Eric C Anderson, Melissa H Wong
Dec 16, 2010·Planta medica·Michal P TurskiWaldemar A Turski
May 28, 2011·Scandinavian Journal of Gastroenterology·Katarzyna WalczakWaldemar A Turski
Mar 7, 2012·Plant Foods for Human Nutrition·Michal P TurskiWaldemar A Turski
Jul 21, 2012·Pharmacological Reports : PR·Katarzyna WalczakWojciech Rzeski
Jun 7, 2014·Pharmacological Reports : PR·Katarzyna WalczakWojciech Rzeski
Aug 29, 2014·Trends in Molecular Medicine·Oscar M Rollano PeñalozaMarek J Łos

❮ Previous
Next ❯

Citations

Feb 25, 2018·Pharmacological Reports : PR·Patrycja Nowicka-StążkaJolanta Parada-Turska
Apr 30, 2020·Cellular and Molecular Life Sciences : CMLS·André StevenBarbara Seliger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis